Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
-
- Ashley Brauning
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Michael Rae
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Gina Zhu
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Elena Fulton
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Tesfahun Dessale Admasu
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Alexandra Stolzing
- SENS Research Foundation, Mountain View, CA 94041, USA
-
- Amit Sharma
- SENS Research Foundation, Mountain View, CA 94041, USA
書誌事項
- 公開日
- 2022-03-17
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.3390/cells11061017
- 公開者
- MDPI AG
説明
<jats:p>Aging is the greatest risk factor for nearly all major chronic diseases, including cardiovascular diseases, cancer, Alzheimer’s and other neurodegenerative diseases of aging. Age-related impairment of immune function (immunosenescence) is one important cause of age-related morbidity and mortality, which may extend beyond its role in infectious disease. One aspect of immunosenescence that has received less attention is age-related natural killer (NK) cell dysfunction, characterized by reduced cytokine secretion and decreased target cell cytotoxicity, accompanied by and despite an increase in NK cell numbers with age. Moreover, recent studies have revealed that NK cells are the central actors in the immunosurveillance of senescent cells, whose age-related accumulation is itself a probable contributor to the chronic sterile low-grade inflammation developed with aging (“inflammaging”). NK cell dysfunction is therefore implicated in the increasing burden of infection, malignancy, inflammatory disorders, and senescent cells with age. This review will focus on recent advances and open questions in understanding the interplay between systemic inflammation, senescence burden, and NK cell dysfunction in the context of aging. Understanding the factors driving and enforcing NK cell aging may potentially lead to therapies countering age-related diseases and underlying drivers of the biological aging process itself.</jats:p>
収録刊行物
-
- Cells
-
Cells 11 (6), 1017-, 2022-03-17
MDPI AG